Thalidomide, Cyclophosphamide, Oral Idarubicin and Dexamethasone (T-CID) in Patients With Multiple Myeloma
Clinical trial NCT00124813 · UNKNOWN
Trial details
- NCT number
- NCT00124813
- Sponsor
- University Hospital, Bonn
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-08-01
- Primary completion
- 2010-05-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.